News Digging > Science > ACMG: Rare Disease Patients in Poor Countries See Benefit from Clinical Whole-Genome Sequencing
ACMG: Rare Disease Patients in Poor Countries See Benefit from Clinical Whole-Genome Sequencing,Patients in Illumina's global iHope philanthropic clinical WGS program saw changes in their management regardless of whether they lived in wealthy or poor countries.

ACMG: Rare Disease Patients in Poor Countries See Benefit from Clinical Whole-Genome Sequencing

Patients in Illumina's global iHope philanthropic clinical WGS program saw changes in their management regardless of whether they lived in wealthy or poor countries.